Abstract Replacement of chemical steps with biocatalytic ones is becoming increasingly more interesting due to the remarkable catalytic properties of enzymes, such as their wide range of substrate specificities and variety of chemo-, stereo-and regioselective reactions. This study presents characterisation of an alcohol dehydrogenase (ADH) from the halophilic archaeum Halobacterium sp. NRC-1 (HsADH2). A hexahistidine-tagged recombinant version of HsADH2 (His-HsADH2) was heterologously overexpressed in Haloferax volcanii. The enzyme was purified in one step by immobilised Ni-affinity chromatography. His-HsADH2 was halophilic and mildly thermophilic with optimal activity for ethanol oxidation at 4 M KCl around 60°C and pH 10.0. The enzyme was extremely stable, retaining 80 % activity after 30 days. HisHsADH2 showed preference for NADP(H) but interestingly retained 60 % activity towards NADH. The enzyme displayed broad substrate specificity, with maximum activity obtained for 1-propanol. The enzyme also accepted secondary alcohols such as 2-butanol and even 1-phenylethanol. In the reductive reaction, working conditions for His-HsADH2 were optimised for acetaldehyde and found to be 4 M KCl and pH 6.0. His-HsADH2 displayed intrinsic organic solvent tolerance, which is highly relevant for biotechnological applications.
Introduction
A range of applications in pharmaceutical and fine chemical industries require the synthesis of chiral alcohols as building blocks [1, 2] . Due to their high chemo-, regio-and stereoselectivity, it is of great interest to replace enantioand regioselective steps in organic syntheses with biocatalytic ones in industrial productions. Many alcohol dehydrogenases (ADHs) display high stereoselectivity and a broad substrate range. Thus the use of stereospecific ADHs has become very interesting from both scientific and industrial perspectives [3] .
Interestingly, ADHs applications are not limited to chiral chemistry and can be used in bioelectrocatalysis for sensors and fuel cells [4] as well as in mild alcohol oxidation for chemical applications [5] .
However, most enzymes are not performing optimally in industrial applications compared to the native aqueous environment [1, 6, 7] and enzymatic syntheses in nonaqueous media have generated significant scientific effort [8] . Due to the limited solubility and stability of dehydrogenases and their cofactors, these enzymes are particularly challenging candidates for the use in organic solvents [8] . Mutagenesis, laboratory evolution or the isolation of natural enzymes from organisms living in appropriate environments may be a way to generate more suitable biocatalysts for industrial processes.
Proteins from Halobacteriaceae are generally functional at high salt concentrations [9] . Compared to non-halophilic homologues, halophilic adaptation usually correlates with a higher content of acidic amino acid residues on the protein surface, contributing to the stability and activity of halophilic enzymes in concentrated salt solutions [10] .
We recently reported on the identification and production of three novel halophilic ADHs [11, 12] . The most promising biocatalyst HvADH2 has also been fully characterised in terms of solvent tolerance [13] . The aim of this study was to clone, purify and characterise yet another halophilic ADH from a different organism Halobacterium sp. NRC-1 and compare characteristics with our previous findings.
Materials and Methods

Strains and Growth Conditions
Unless stated otherwise, Escherichia coli XL10-Gold Ò cells were grown in the presence of ampicillin (100 lg/mL) in Luria-Bertani (LB) broth at 37°C in an orbital shaker at 250 rpm or on LB agar (2 %). H. volcanii H1209 and H1325 cells were cultured in Hv-YPC agar and Hv-YPC broth (YPC) or agar (1.7 %) [14] . Liquid cultures were grown at 45°C and 220 rpm and the expression of recombinant proteins was induced by the addition of L-tryptophan (5 mM) at the start of growth.
Preparation of Halobacterium sp. NRC-1 DNA and Amplification of adh2 Gene Halobacterium sp. NRC-1 was kindly provided by Prof. P. Engel (University College Dublin, Ireland). Genomic DNA of H. sp. NRC-1 was isolated using the Wizard Ò genomic DNA purification kit. Primers adh2_Hsal_fw, adh2_PciI_fw and adh2_Hsal_rev (Table 1) targeting the adh2 gene were designed on the basis of the published nucleotide sequence (GenBank AE004437) to include restriction sites for NdeI, PciI and EcoRI, respectively. The adh2 gene was amplified in 50 lL reactions containing 0.5 lM of each primer, 200 lM dNTPs, 0.5 ng of genomic DNA and 1 U of Phusion TM DNA polymerase in Phusion TM GC buffer (Finnzymes). Cycling conditions were a hot-start at 98°C for 30 s, followed by 35 cycles of denaturation for 10 s at 98°C, annealing for 25 s at 72°C and extension for 17 s at 72°C. A final extension at 72°C was employed for 7 min. Successful amplification was confirmed by agarose gel electrophoresis in comparison to a negative control from which DNA was omitted.
Cloning of adh2
The PCR products were first cloned into pSTBlue-1 using the AccepTor TM Vector Kit (Merck) under manufacturer's instructions. Correct amplification and successful cloning were confirmed by bi-directional sequencing (MWG, Germany) using primers SP6 and T7 (Table 1 ) and comparison to the published nucleotide sequence (GenBank AE004437).
The adh2 gene was then extracted from pSTBlue-1 and ligated into the H. volcanii vector pTA963 (provided by Dr. Allers et al. [15] ) by a sequential restriction digest of pSTBlue-1.adh2 and pTA963, respectively, using restriction enzymes EcoRI and NdeI (New England Biolabs, 1 U/mL) in their recommended buffers buffer at 37°C for 2.5 h each. Additionally, adh2 was cloned into pTA963 using PciI and EcoRI (1 U/mL), retaining the vector's His-tag. Restriction products were visualized on a 0.8 % agarose gel containing ethidium bromide (0.5 lg/mL). Appropriate bands were excised and extracted using the Roche Agarose gel extraction Kit according to manufacturer's instructions. Ligations (10 lL) were performed using molar insert-to-vector ratios of at least 2:1 and 1 U T4 DNA ligase (New England Biolabs) in its supplied buffer, at 16°C overnight. Ligation products were introduced into E. coli XL10-Gold Ò (Stratagene) ultracompetent cells by heat shock transformation and transformants were grown on LB agar and ampicillin. Positive colonies were inoculated into LB broth supplemented with ampicillin and grown overnight for plasmid extraction using the PureYield TM Plasmid Miniprep System (Promega) according to manufacturer's instructions. Extracted plasmids were sent for bi-directional sequencing (MWG, Germany) using primers pTA963_fw and pTA963_rev (Table 1) , to confirm successful ligation. Resulting constructs are listed in Table 1 .
Strains and Transformation Protocols
The E. coli strain for plasmid production and storage was XL10-Gold Ò (Stratagene). Chemically competent E. coli cells were prepared and transformed following standard procedures.
Haloferax volcanii H1209 and H1325 competent cells were prepared according to the Halohandbook and transformed using the standard PEG-mediated transformation of haloarchaea [14] . H. volcanii H1209 and H1325 cells were transformed with pTA963 (empty vector), pTA963.adh2 (containing adh2 gene without tag) and pTA963.hisadh2 (containing adh2 gene with His-tag) and plated on Hv-YPC agar. Plates were incubated at 45°C for about 5 days until colonies were visible followed by further incubation at room temperature until colonies turned pink.
Expression of His-HsADH2 in Haloferax volcanii
Starter cultures of H. volcanii (H1209 and H1325) transformed with pTA963 and pTA963.hisadh2 were cultured in liquid Hv-YPC (5 mL) and grown for 48 h at 45°C in a rotary shaker at 220 rpm and used to inoculate 270 mL Hv-YPC broth. Immediately after inoculation, protein expression was induced by addition of L-tryptophan to a final concentration of 5 mM. The culture was shaken for up to 48 h following induction. Cultures were harvested by centrifugation at 3,5009g for 8 min in a bench-top centrifuge (Hettich, Rotina-38). Cells were resuspended in 100 mM Tris-HCl buffer, pH 7.5, containing NaCl (2 M) and disodium EDTA (2 mM) and lysed by repeated sonication with a 6-mm microtip at 50 % amplitude in 30 s intervals. The lysate was centrifuged at 18,000 rpm, 4°C (Sorval, SS-34 rotor) and the supernatant was filtered through a 0.45-lm filter (Anachem). The supernatant was assayed for ADH activity.
Purification of His-HsADH2 by IMAC
Clarified cell-free extract was loaded onto a 1-mL His-trap FF column (GE Healthcare) equilibrated with 20 mM TrisHCl buffer, pH 8.0, containing imidazole (20 mM) and NaCl (2 M), at a flow rate of 0.5 mL/min. The loaded column was washed extensively with 20 mM Tris-HCl buffer, pH 8.0, containing NaCl (2 M) to remove non-specifically bound protein. A stepwise elution was performed using 10 mM EDTA followed by 20 mM EDTA, in order to elute the His-tagged protein. Fractions (1 mL) were collected and assayed spectrophotometrically for ADH activity. Active fractions were visualized on a 12 % SDS-PAGE gel stained with Coomassie brilliant blue R250. Staining and destaining was performed using the Stain/Destain-Xpress TM protein detection kit (Enzolve Technologies Ltd., Ireland). A broad range protein marker, P7702S, (2-212 kDa) (New England Biolabs, USA) was used for determination of relative molecular weight. Fractions selected, based on purity and specific activity, were pooled and dialyzed overnight against 50 mM Tris-HCl buffer, pH 7.5, containing NaCl (2 M) at 4°C overnight. Purified HsADH2 was routinely stored at -20°C. Protein concentrations were determined as previously described [11] .
Determination of His-HsADH2 Activity Activity assays were performed as described previously [11] . The reaction mixture for the oxidative step routinely contained 1-propanol (100 mM), NAD(P)
(1 mM), enzyme sample (10 lL of suitable enzyme concentration), and 50 mM glycine-KOH, pH 10.0, containing KCl (4 M). The reaction mixture for the reduction step contained acetaldehyde (50 mM), NAD(P)H (0.1 mM), 10 lL of suitable enzyme concentration, and 50 mM citric acid-K 2 HPO 4 , pH 6.0 containing KCl (4 M). Unless stated otherwise, assays were performed in a 1 mL reaction volume in a 50 mM buffer, 100 mM alcohol or 50 mM aldehyde and 1 mM or 0.1 mM NAD(P)H, respectively, at 50°C for 1 min.
Characterisation of His-HsADH2
For the oxidative reaction a range of buffers based on either KCl or NaCl, ranging from 1 to 4 M of salt, and pH 8.0-11.0 were tested. Buffers used were Tris-HCl (pH 8.0), glycine-KOH or -NaOH (pH 9.0-10.0) and Na 2 PO 4 -NaOH or K 2 PO 4 -KOH (pH 11.0). Conditions for the reductive reaction were tested with buffers ranging from 1 to 4 M KCl and pH 5.0-8.0, using buffers Citric acid-K 2 PO 4 (pH 5.0), KP i (pH 6.0) and Tris-HCl (pH 7.0 and 8.0). The substrate specificity of His-HsADH2 was investigated by screening for ADH activity against a range of alcohol substrates (100 mM) ethanol, 1-propanol, 1-butanol, 2-propanol, 2-butanol, benzyl alcohol and 1-phenylethanol. The coenzyme dependency was determined using both nicotinamide coenzymes (1 mM). The effect of storage temperature on His-HsADH2 activity was monitored by assaying purified enzyme stored at 4°C and -20°C for activity. The optimal temperatures for the bioconversion were determined by screening enzyme activity at temperatures ranging from 40 to 70°C in the oxidative reaction. To investigate organic solvent tolerance, His-HsADH2 was incubated for 24 h at 4°C in 100 mM Tris-HCl, buffer, pH 7.5, containing NaCl (2 M) with 5, 10 and 30 % (v/v) organic solvents, dimethyl sulphoxide (DMSO), acetonitrile (ACN), methanol (MeOH) and tetrahydrofuran (THF). The enzyme was assayed for activity at time zero and after incubation. Kinetics measurements for the oxidative reaction enzyme assays were performed over a range of concentrations for ethanol (screened between 0 and 300 mM), 1-propanol (0-120 mM) and NADP ? (0-2 mM). For the reductive reaction enzyme assays were performed over a range of concentrations of acetaldehyde (0-100 mM) and NADPH (0-0.5 mM). Kinetic data were plotted using MMfit version 1.2.0 (Macintosh) and GraphPad Prism 5 version 5.0 (Windows) with nonlinear regression analysis [16] .
Results and Discussion
In a continuing effort to identify and produce interesting halophilic ADHs, our aim was to efficiently express adh2 from Halobacterium sp. NRC-1 and investigate its catalytic properties with regard to its substrate spectrum and solvent tolerance.
Screening for adh Genes
The genome of Halobacterium sp. NRC-1 was sequenced and annotated by Ng et al. [17] and indicated the presence of 5 adhs (ID 1448607, 1448961, 1447734, 1448333, 1448186 [17] ). Alignment of these enzymes against manually cured protein families (chosen from UniProKB/Swiss Prot) using Blastp [18, 19] , indicated that adh2 (gene ID 1448961, protein NP_281175) had putative activity towards hydroxyl groups and belonged to the family of zinc-dependent class I ADHs. Further multiple alignment to the class I ADHs using ClustalW2 [20] showed homologies to the family of zincdependent ADHs, including the conserved structural zincbinding cysteine residues (Cys 89, 92, 95, 103 ), the catalytic zinc binding residues (Cys ). When selectively comparing the sequence of HsADH2 with the previously described HvADH2 [12] we observed a very high sequence similarity (82 %) and 68 % identity.
Comparison of Levels of Expression of HsADH2 and His-HsADH2
Expression levels between the untagged and tagged adh2 varied strongly. His-HsADH2 reached activity levels in the crude extract of 0.7 U/mg while untagged adh2 was 0.04 U/mg. The specific activity of His-HsADH2 was *20 times higher than the untagged enzyme in the crude extract.
While the addition of a His-tag can sometimes hamper the expression and activity of enzymes, this does not seem to be the case here [21] .
Optimisation of Expression of His-HsADH2
The conditional overexpression system developed by Allers et al. [15] was employed for the heterologous overexpression of His-HsADH2. The gene hs.adh2 was cloned into pTA963 to generate either a hexahistidinetagged expression construct or just the native protein HsADH2 and initially expressed in H. volcanii strain H1209. SDS-PAGE was not sufficiently sensitive to detect His-HsADH2 in the crude lysate from H1209 cells indicating that expression levels required optimisation. Furthermore, the first attempted purification for the HisHsADH2 from this system did not yield protein of sufficient purity for characterisation. The host strain was therefore changed to H1325, which had proved to be successful for the expression and cleaner preparation of other halophilic ADHs. From this strain endogenous ADHs have been deleted eliminating any possible cross-contamination or hybrid protein generation [12] . Due to the poor expression levels obtained with the non His-tagged ADH2, further work was performed only with the His-HsADH2. From small-scale (30 mL) overexpression, the best activity was seen when L-tryptophan was added at the start of growth and so this was employed for the scale-up 300 mL flasks. Activity was also assessed in the crude extract of a control strain harbouring the empty pTA963 vector. No ADH activity was ever observed with the empty vector under the conditions tested. Extending growth time relatively to the procedure we developed before [11] , significantly improved the expression of His-HsADH2.
Purification of His-HsADH2
His-HsADH2 was purified by immobilised Ni-affinity chromatography (IMAC) in one step. Stepwise elution with 10 mM followed by 20 mM EDTA resulted in 8 active fractions; the most active fractions were pooled and analyzed by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) (Fig. 1) , which revealed a band approximately corresponding to the subunit molecular weight of His-HsADH2 (37.3 kDa). After overnight dialysis to remove EDTA, the specific activity of HisHsADH2 was 7.7 U/mg, compared to 0.7 U/mg in the crude lysate, indicating a purification factor of 11. Purified His-HsADH2 was routinely stored at -20°C in a buffer containing NaCl (2 M) at pH 7.5.
Characterisation of His-HsADH2
The purified His-HsADH2 showed a preference for NADP(H) even though it retained 60 % of activity towards NAD(H) at 4 M KCl and pH 10. A dual cofactor dependency is industrially relevant as the phosphorylated cofactor is prohibitively expensive [22] . A preference for KCl over NaCl was observed, with best activity at 4 M KCl. In the oxidative reaction activity increased with increasing pH up to pH 10, while the optimum pH for reduction was pH 6. This is quite commonly observed for halophilic enzymes [23] [24] [25] . The optimum reaction temperature for oxidation was between 55 and 60°C.
His-HsADH2 displayed a preference for short-chain alcohol substrates, particularly for 1-propanol (100 %) and ethanol (84 %) (Fig. 2) .
Considerable activity was detected with medium-chain alcohols 1-butanol (40 %) and the secondary alcohol counterpart 2-butanol (30 %). His-HsADH2 also accepted aromatic alcohols such as 1-phenylethanol (35 %) and benzyl alcohol (21 %). Methanol and glycerol did not serve as substrates. From our previous study it was shown that the substrate specificity of His-HvADH2 was strongly salt dependent and accordingly, the substrate specificity of HisHsADH2 was tested against a range of salt concentrations from 1 to 4 M KCl. For all alcohol substrates tested, maximum activity was detected in 4 M KCl. His-HsADH2 catalyzed the reductive reaction optimally at pH 6.0 with 4 M KCl.
Enzyme kinetic experiments revealed that His-HsADH2 followed Michaelis-Menten kinetics with 1-propanol, ethanol, NADP ? , acetaldehyde and NADPH. Kinetic experiments confirmed that 1-propanol was the favoured substrate over ethanol with K m values of 21.4 and 107.9 mM, respectively ( Table 2 ). The estimated maximum velocities were 8.1 and 10.5 U/mg, respectively. Values measured for acetaldehyde and NADPH were in the range of 3.4 mM and 50 lM (K m ) and of 7.1 and 5.7 U/mg (V max ) for acetaldehyde and NADPH, respectively. HisHsADH2 had a good affinity for acetaldehyde with a K m of 3.4 mM that is 30 times lower compared to that of ethanol. Hence, this enzyme could play an important role in aldehyde reduction rather than alcohol oxidation.
Stability of His-HsADH2 had a similar profile to that of His-HvADH2, the purified enzyme retained 80 % of its original activity following incubation at -20°C for Fig. 2 His-HsADH2 activity against a range of alcohol substrates. His-HsADH2 was assayed for activity against methanol, 1-propanol, ethanol, 1-butanol, 2-propanol, 2-butanol, glycerol, benzyl alcohol and 1-phenylethanol. The results were expressed as relative activities (%) with respect to 1-propanol 30 days. His-HsADH2 was less stable at 4°C with a retained activity of *15 % after 20 days. Owing to the impressive solvent tolerance reported for His-HvADH2 [13] , we hypothesised that His-HsADH2 would also have this characteristic resilience. The effects of organic solvents at 5, 10 and 30 % (v/v) on the stability of His-HsADH2 were tested following a 24-h incubation at 4°C with DMSO, ACN, MeOH and THF. His-HsADH2 was incubated in a mixture of organic solvents and 100 mM Tris-HCl buffer, pH 7.5 containing 2 M NaCl at 4°C. The residual activity was measured after 24 h. Results from the incubation revealed that His-HsADH2 was also extremely stable in the presence of organic solvents, particularly towards 10 % (v/v) organic solvents (Table 3) . His-HsADH2 was stable in the presence of 5 % (v/v) DMSO, ACN and MeOH. Increasing the concentration to 10 % (v/v) yielded impressive residual activity (85-91 %), which was very similar to the results with 5 % (v/v) co-solvent (89-92 %). This result with 10 % (v/v) co-solvent is higher for His-HsADH2 (residual activity 85-91 %) than for His-HvADH2 (74-77 %) hence HisHsADH2 has great potential as a biocatalyst in aqueousorganic media. His-HsADH2 displayed higher tolerance to THF (10 %) than His-HvADH2 retaining 43 % residual activity in comparison to 12 %.
Tolerance in the presence of 30 % DMSO was comparable with our report for His-HvADH2; however, HisHsADH2 was inactivated when incubated in 30 % ACN and THF. Stability in the presence of high concentration co-solvents could be improved by directed evolution.
Conclusions
The aim of this study was to efficiently express adh2 from Halobacterium sp. NRC-1 in H. volcanii and investigate its catalytic properties with regard to its substrate spectrum. In conclusion, the adh2 from Halobacterium sp. NRC-1 showed typical halophilic characteristics. It required high salt concentrations for its activity and was mildly alkaliphilic and thermophilic. His-HsADH2 accepted a broad range of substrates with a preference for short-chain alcohols and maintaining activity towards aromatic substrates. There is potential to exploit the enzyme in the reduction reaction. His-Hs-ADH2 demonstrated higher tolerance towards 10 % (v/v) organic solvents as compared to HisHvADH2. Furthermore, the remarkable stability of HisHsADH2 in organic solvents can be exploited in the scaleup of biocatalytic reactions. The K m is presented in mM, V max in U/mg 
